Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

4-hydroxyatomoxetine

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PhenolsPropylamines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Determination of atomoxetine and its metabolites in conventional and non-conventional biological matrices by liquid chromatography-tandem mass spectrometry.
A procedure based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) is described for determination of atomoxetine (ATX… Expand
  • figure 2
  • table 2
  • table 3
Review
2005
Review
2005
Clinical Pharmacokinetics of Atomoxetine
Atomoxetine (Strattera®), a potent and selective inhibitor of the presynaptic norepinephrine transporter, is used clinically for… Expand
Review
2004
Review
2004
Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder.
UNLABELLED Atomoxetine (Strattera) is a selective norepinephrine reuptake inhibitor and nonstimulant that has shown greater… Expand
  • table I
  • table II
  • figure 1
  • figure 2
Highly Cited
2004
Highly Cited
2004
Atomoxetine Hydrochloride: Clinical Drug-Drug Interaction Prediction and Outcome
In the studies reported here, the ability of atomoxetine hydrochloride (Strattera) to inhibit or induce the metabolic… Expand
  • table 1
  • table 2
  • table 3
  • figure 2
  • table 5
Highly Cited
2003
Highly Cited
2003
Disposition and metabolic fate of atomoxetine hydrochloride: the role of CYP2D6 in human disposition and metabolism.
The role of the polymorphic cytochrome p450 2D6 (CYP2D6) in the pharmacokinetics of atomoxetine hydrochloride [(-)-N-methyl-gamma… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Highly Cited
2003
Highly Cited
2003
Effect of hepatic impairment on the pharmacokinetics of atomoxetine and its metabolites
Atomoxetine is a treatment for attention‐deficit/hyperactivity disorder and is primarily eliminated via cytochrome P4502D6… Expand
Highly Cited
2003
Highly Cited
2003
Atomoxetine pharmacokinetics in children and adolescents with attention deficit hyperactivity disorder.
OBJECTIVE Atomoxetine is indicated for the treatment of attention deficit hyperactivity disorder in children, adolescents, and… Expand
2003
2003
Disposition and metabolic fate of atomoxetine hydrochloride: pharmacokinetics, metabolism, and excretion in the Fischer 344 rat and beagle dog.
These studies were designed to characterize the disposition and metabolism of atomoxetine hydrochloride [(-)-N-methyl-gamma-(2… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Highly Cited
2002
Highly Cited
2002
Identification of the human cytochromes P450 responsible for atomoxetine metabolism.
Studies were performed to determine the human enzymes responsible for the biotransformation of atomoxetine to its major… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Highly Cited
2002
Highly Cited
2002
Effect of Potent CYP2D6 Inhibition by Paroxetine on Atomoxetine Pharmacokinetics
The purpose of this study was to characterize the effect of potent CYP2D6 inhibition by paroxetine on atomoxetine disposition in… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE